VEINAMINE 8%
LOE Approachingamino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate
NDAINJECTIONINJECTABLE
Approved
Jan 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VEINAMINE 8% is a sterile injectable amino acid solution with electrolytes (magnesium, potassium, sodium) used for parenteral nutritional support in patients unable to meet nutritional needs orally or enterally. It provides essential amino acids and key minerals to maintain protein synthesis and electrolyte balance during critical illness, post-operative recovery, or chronic malnutrition. This is a foundational nutrition support therapy rather than a disease-targeted drug.
LOE Approaching
As LOE approaches with moderate competitive pressure (30), brand defense roles and transition planning will become critical; expect smaller, specialized teams focused on retention and cost optimization.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VEINAMINE 8% as LOE approaches offers careers centered on operational efficiency, regulatory maintenance, pricing strategy, and customer retention rather than growth marketing or innovation. This is a stable but declining opportunity best suited for professionals focused on mature product management, supply reliability, and payer relationships.
Supply Chain Manager
Worked on VEINAMINE 8% at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.